Clinical Trial Update: Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial comparing HPN-100 to sodium phenylbutyrate in children with urea cycle disorders to assess safety and tolerability. The study is completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urea Cycle Disorders

Drugs mentioned

• HPN-100
• Sodium phenylbutyrate (sodium phenylbutyrate)

Snippet

Sponsor: Amgen | Conditions: Urea Cycle Disorders | Phase 2 | Status: COMPLETED | Results posted: 2013-12-25